SCHEMBL8271560

SCHEMBL8271560

CC#CCn1c(N(C)CC(C)N)nc2c1c(=O)n(Cc1nc3ccccc3c(=O)[nH]1)c(=O)n2C

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 18/20 0.45
▸ FAP Q12884 10/20 0.45
▸ DPP9 Q86TI2 2/20 0.43
▸ POU2F2 P09086 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ POU2F1 P14859 1/20 0.43
▸ CHRM3 P20309 1/20 0.43
▸ HRH2 P25021 1/20 0.43
▸ MC4R P32245 1/20 0.43
▸ DPP8 Q6V1X1 1/20 0.43
▸ GHSR Q92847 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273231 0.86 DPP4 (0.45) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL196303 0.85 DPP4 (0.61) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL8272340 0.85 DPP4 (0.51) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL4474769 0.85 DPP4 (0.61) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL29801431 0.85 DPP4 (0.61) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL196304 0.85 DPP4 (0.61) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL682159 0.84 DPP4 (0.45) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL8272356 0.83 DPP4 (0.56) DPP4
SCHEMBL9290400 0.82 DPP4 (0.43) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL8272341 0.82 DPP4 (0.46) DPP4FAPDPP9POU2F2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797093-B1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2012-05-30 — — EP disclosed
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 — — US disclosed
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 — — US disclosed
WO-2006029769-A1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-23 — — WO disclosed
Send feedback